3
6
O. S. Grigorkevich et al.
7
8
9
. P. Jain, C. Saravanan, and S. K. Singh, Eur. J. Med. Chem., 60,
keeping conditions were compliant with standard SP
.2.1.3218-14 “Sanitary Epidemiological Requirements for
8
9 – 100 (2013).
. T. J. Peterson, H. Hallak, L. Johnson, et al., Circulation, 103,
303 – 2309 (2001).
. L. E. Rohde, A. Ducharme, L. H. Arroyo, et al., J. Am. Heart
Assoc., 3063 – 3070 (1999).
0. W. M. Yarbrough, R. Mukherjee, G. P. Escobar, et al., Circula-
tion, 108, 1753 – 1759 (2003).
2
the Fittings, Equipment, and Facilities of Experimental Bio-
logical Clinics (Animal Houses),” August 29, 2014, No. 51.
LD50 values for the compounds synthesized here were
tested in experiments on mongrel male mice weighing
2
1
2
1 – 24 g. Compounds were given i.p. The solvent was
apyrogenic water for injection. The acute toxicity of each
compound was determined using at least five different doses
and the number of animals in each series was six. Lethality
was assessed 24 h after administration of compounds. The
Litchfield-Wilcoxon method was used to determine the LD50
with 95% confidence intervals (Table 3).
11. M. P. Hudson, P. W. Armstrong, W. Ruzyllo, et al., J. Am. Coll.
Cardiol., 48, 15 – 20 (2006).
12. R. P. Verma and S. Hansch, Bioorg. Med. Chem., 5,
2
223 – 2268 (2007).
3. D. P. Becker, T. E. Barta, L. J. Bedell, et al., J. Med. Chem., 53,
653 – 6680 (2010).
4. J. M. Cathcart and J. Cao, Frontiers in Bioscience, Landmark,
0, 1164 – 1178 (2015).
5. M. Whittaker, C. D. Floyd, P. Brown, et al., Chem. Rev., 99,
735 – 2776 (1999).
1
1
1
6
Ex vivo biological activity was studied in mongrel male
rats weighing 200 – 220 g. Animals were randomized to
2
1
0 groups each of six individuals: 1) intact; 2) control, MI; 3)
2
MI + reference agent doxycycline; 4 – 10) groups receiving
newly synthesized compounds VIa, VIb, VIc, VId, and VIe
respectively. Reference agent doxycycline (40 mg/kg/day)
and study compounds (20 mg/kg/day) were given via
intragastric tube in 0.5 ml of physiological saline for the
three days preceding the experiment. Animals anesthetized
with urethane (1300 mg/kg, i.p.) were intubated and mechan-
ically ventilated. After thoracotomy and pericardiotomy, the
left coronary artery was identified was ligated at the level of
the exit of the vessel from the auricle. At 3 h after ligation of
the coronary artery, animals were sacrificed and blood was
collected, centrifuged for 20 min at 2000 rpm, serum was
collected and stored at -20°C until immunoenzyme assay of
the plasma MMP-9 level. MMP-9 was assayed using a Chem
Well 2901 Combi (USA) automated biochemical and immu-
noenzyme analyzer. Experiments used an RMP900 kit for
immunoenzyme assay of rat MMP-9 (R&D Systems, USA).
Normal distributions of datasets were confirmed using
the Shapiro-Wilks test and the homogeneity of dispersions
by the Levene test. As datasets had normal or near-normal
distributions and dispersions were homogeneous. Statistical
significance was determined by single-factor analysis of
variance with subsequent multiple comparisons using the
Newman-Keuls test. Results are expressed as arithmetic
means and standard errors. The critical significance level
was p = 0.05.
16. G. Cerisano, P. Buonamici, A. M. Gori, et al., Int. J. Cardiol.,
197, 147 – 153 (2015).
17. G. Cerisano, P. Buonamici, R. Valenti, et al., Eur. Heart J., 1 – 8
(
2013).
1
1
2
8. G. Cerisano, P. Buonamici, R. Valenti, et al., Basic Res.
Cardiol., 1 – 9 (2014).
9. T. Sadowski and J. Steinmeyer, Inflamm. Res., 50(3), 175 – 82
(
2001).
0. M. L. Lindsey, Global J. Hum. Anat. Physiol. Res., 1, 6 – 9
2014).
(
21. C. Camodeca, E. Nuti, L. Tepshi, et al., Eur. J. Med. Chem., 111,
193 – 201 (2016).
22. R. Oltenfreiter, L. Staelens, A. Lejeune, et al., Nucl. Med. Biol.,
3
1, 459 – 468 (2004).
3. A. Tochowicz, K. Maskos, R. Huber, et al., J. Mol. Biol., 371,
89 – 1006 (2007).
4. M. Whittaker and A. Ayscough, Celltransmissions, 17(1),
– 14 (2001).
2
2
9
3
2
2
2
5. B. Pirad and H. Matter, J. Med. Chem., 49(1), 51 – 69 (2006).
6. US Patent No. 5985900 A (1999).
7. Y. Tamura, F. Watanabe, T. Nakatani, et al., J. Med. Chem., 41,
640 – 649 (1998).
28. D. Yamamoto and S. Takai, Cur. Med. Chem., 16, 1349 – 1354
2009).
(
2
3
3
9. R. A. Friesner, R. B. Murphy, M. P. Repasky, et al., J. Med.
Chem., 49, 6177 – 6196 (2006).
0. T. A. Halgren, R. B. Murphy, R. A. Friesner, et al., J. Med.
Chem., 47, 1750 – 1759 (2004).
1. Schrödinger Release 2015-4: Maestro, version 10.4,
Schrödinger, LLC, New York, NY (2015).
REFERENCES
32. R. J. Cremlyn, F. S. Swinbourne, A. Batchelor, et al., Indian J.
Chem., Section B: Organic Chem. Including Med. Chem., 2,
No. 10, 1029 – 1043 (1983).
1
. P. Van Lint and C. Libert, J. Leukoc. Biol., 82, 1375 – 1381
2007).
. M. Hori and K. Nishida, Cardiovasc. Res., 81(3), 457 – 464
2009).
. F. G. Spinale, Physiol. Rev., 87, 1285 – 1342 (2007).
. A. G. Gasanov and T. V. Bershova, Biomed. Khim., 55(2),
55 – 168 (2009).
. K. S. Moshal, Physiol. Res., 57, 379 – 384 (2008).
. J. Simova and J. J. Serum, Folia Biol., 59(5), 181 – 187 (2013).
33. Y. Wang, D. Zhu, L. Tang, et al., Angew. Chem. Int. Ed., 50,
(
8917 (2011).
2
(
34. M. Tamura, D. Murase and K. Komura, Synthesis (Germany),
47(6), 769 – 776 (2015).
3
4
35. A. Van den Nieuwendijk, D. Pietra, L. Heitman, et al., J. Med.
Chem., 47, 663 – 672 (2004).
1
5
6
36. J. DeRuiter, R. F. Borne, and C. A. Mayfield, J. Med. Chem.,
32(1), 145 – 151 (1989).